Skip to main content
OpenTrials

Clinical trial condition

Low and Int 1-risk Myelodysplastic Syndrome

Explore clinical trials studying Low and Int 1-risk Myelodysplastic Syndrome. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Low and Int 1-risk Myelodysplastic Syndrome trial results

Completed

Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.

NCT01868477

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +6 more
Locations
  • Novartis Investigative Site Oran, Algeria
  • Novartis Investigative Site Sidi Bel Abbes, Algeria
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site La Plata, Buenos Aires, Argentina
View all 30 locations
View Trial Details

Related conditions